Recently added Catalysts

BAX

Document BAXTER INTERNATIONAL INC. Net Sales by Segment (unaudited, in millions) Years Ended December 31, Reported Growth Constant Currency Growth 2020 2019 2018 2020 2019 2020 2019 Net sales by segment Americas $ 6,321

Monday, April 26, 2021 1 min read

Key Takeaway: BAXTER INTERNATIONAL INC. Net Sales by Segment (unaudited, in millions) Years Ended December 31, Reported Growth Constant Currency Growth 2020 2019 2018 2020 2019 2020 2019 Net sales by segment Americas $ 6,321 $ 6,306 $ 6,156 0 % 2 %

Full Press Release Details

BAXTER INTERNATIONAL INC.

Net Sales by Segment

(unaudited, in millions)

	Years Ended December 31,
					Reported Growth		Constant Currency Growth
	2020	2019	2018		2020	2019		2020	2019
Net sales by segment
Americas	$	6,321		$	6,306		$	6,156			0	%	2	%		2	%	4	%
EMEA	2,877		2,756		2,741			4	%	1	%		4	%	5	%
APAC	2,475		2,300		2,202			8	%	4	%		7	%	8	%
Total net sales	$	11,673		$	11,362		$	11,099			3	%	2	%		3	%	5	%

	Quarters Ended December 31,
					Reported Growth		Constant Currency Growth
	2020	2019	2018		2020	2019		2020	2019
Net sales by segment
Americas	$	1,681		$	1,685		$	1,551			(0)	%	9	%		1	%	9	%
EMEA	800		736		707			9	%	4	%		4	%	6	%
APAC	700		618		575			13	%	7	%		8	%	9	%
Total net sales	$	3,181		$	3,039		$	2,833			5	%	7	%		3	%	8	%

	Quarters Ended September 30,
					Reported Growth		Constant Currency Growth
	2020	2019	2018		2020	2019		2020	2019
Net sales by segment
Americas	$	1,606		$	1,585		$	1,547			1	%	2	%		3	%	4	%
EMEA	720		679		657			6	%	3	%		3	%	7	%
APAC	646		587		557			10	%	5	%		7	%	8	%
Total net sales	$	2,972		$	2,851		$	2,761			4	%	3	%		4	%	5	%

	Quarters Ended June 30,
					Reported Growth		Constant Currency Growth
	2020	2019	2018		2020	2019		2020	2019
Net sales by segment
Americas	$	1,469		$	1,577		$	1,568			(7)	%	1	%		(4)	%	2	%
EMEA	669		684		691			(2)	%	(1)	%		0	%	5	%
APAC	580		573		554			1	%	3	%		5	%	9	%
Total net sales	$	2,718		$	2,834		$	2,813			(4)	%	1	%		(1)	%	4	%

	Quarters Ended March 31,
					Reported Growth		Constant Currency Growth
	2020	2019	2018		2020	2019		2020	2019
Net sales by segment
Americas	$	1,565		$	1,459		$	1,490			7	%	(2)	%		8	%	(0)	%
EMEA	688		657		686			5	%	(4)	%		8	%	3	%
APAC	549		522		516			5	%	1	%		9	%	7	%
Total net sales	$	2,802		$	2,638		$	2,692			6	%	(2)	%		8	%	2	%

BAXTER INTERNATIONAL INC.

Operating Income by Segment

(unaudited, in millions)

	Years Ended December 31,
	2020	2019	2018
Operating income by segment
Americas	$	2,389		$	2,499		$	2,533
EMEA	523		527		544
APAC	591		549		532
Total segment operating income	3,503		3,575		3,609
Corporate and other	(1,887)		(1,803)		(2,025)
Total operating income	$	1,616		$	1,772		$	1,584

	Quarters Ended December 31,
	2020	2019	2018
Operating income by segment
Americas	$	663		$	688		$	638
EMEA	159		158		155
APAC	159		155		149
Total segment operating income	981		1,001		942
Corporate and other	(575)		(465)		(551)
Total operating income	$	406		$	536		$	391

	Quarters Ended September 30,
	2020	2019	2018
Operating income by segment
Americas	$	611		$	625		$	651
EMEA	126		132		137
APAC	161		138		137
Total segment operating income	898		895		925
Corporate and other	(428)		(392)		(543)
Total operating income	$	470		$	503		$	382

	Quarters Ended June 30,
	2020	2019	2018
Operating income by segment
Americas	$	527		$	617		$	648
EMEA	121		124		130
APAC	143		136		131
Total segment operating income	791		877		909
Corporate and other	(460)		(527)		(532)
Total operating income	$	331		$	350		$	377

	Quarters Ended March 31,
	2020	2019	2018
Operating income by segment
Americas	$	588		$	569		$	596
EMEA	117		113		122
APAC	128		120		115
Total segment operating income	833		802		833
Corporate and other	(424)		(419)		(399)
Total operating income	$	409		$	383		$	434

BAXTER INTERNATIONAL INC.

Net Sales by Product Category

(unaudited, in millions)

	Years Ended December 31,
													Reported Growth		Constant Currency Growth
	2020		2019		2018		2020		2019		2020		2019
	U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total
Net sales by product category
Renal Care	$	848		$	2,909		$	3,757			$	791		$	2,848		$	3,639			$	816		$	2,835		$	3,651			7	%	2	%	3	%		(3)	%	0	%	(0)	%		7	%	3	%	4	%		(3)	%	5	%	3	%
Medication Delivery	1,738		953		2,691			1,762		977		2,739			1,652		974		2,626			(1)	%	(2)	%	(2)	%		7	%	0	%	4	%		(1)	%	(1)	%	(1)	%		7	%	5	%	6	%
Pharmaceuticals	849		1,249		2,098			904		1,215		2,119			976		1,091		2,067			(6)	%	3	%	(1)	%		(7)	%	11	%	3	%		(6)	%	3	%	(1)	%		(7)	%	17	%	5	%
Clinical Nutrition	330		580		910			308		552		860			313		554		867			7	%	5	%	6	%		(2)	%	(0)	%	(1)	%		7	%	5	%	6	%		(2)	%	4	%	2	%
Advanced Surgery	516		370		886			533		342		875			465		332		797			(3)	%	8	%	1	%		15	%	3	%	10	%		(3)	%	8	%	1	%		15	%	8	%	12	%
Acute Therapies	286		454		740			184		351		535			174		341		515			55	%	29	%	38	%		6	%	3	%	4	%		55	%	30	%	39	%		6	%	8	%	7	%
BioPharma Solutions	234		252		486			257		212		469			244		205		449			(9)	%	19	%	4	%		5	%	3	%	4	%		(9)	%	17	%	3	%		5	%	9	%	7	%
Other	77		28		105			87		39		126			83		44		127			(11)	%	(28)	%	(17)	%		5	%	(11)	%	(1)	%		(11)	%	(28)	%	(17)	%		5	%	(9)	%	0	%
Total Baxter	$	4,878		$	6,795		$	11,673			$	4,826		$	6,536		$	11,362			$	4,723		$	6,376		$	11,099			1	%	4	%	3	%		2	%	3	%	2	%		1	%	5	%	3	%		2	%	7	%	5	%

	Quarters Ended December 31,
													Reported Growth		Constant Currency Growth
	2020		2019		2018		2020		2019		2020		2019
	U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total
Net sales by product category
Renal Care	$	219		$	794		$	1,013			$	204		$	756		$	960			$	207		$	744		$	951			7	%	5	%	6	%		(1)	%	2	%	1	%		7	%	3	%	4	%		(1)	%	3	%	2	%
Medication Delivery	476		267		743			495		261		756			401		248		649			(4)	%	2	%	(2)	%		23	%	5	%	16	%		(4)	%	1	%	(2)	%		23	%	8	%	17	%
Pharmaceuticals	212		350		562			240		330		570			241		288		529			(12)	%	6	%	(1)	%		(0)	%	15	%	8	%		(12)	%	2	%	(4)	%		(0)	%	17	%	9	%
Clinical Nutrition	89		154		243			80		149		229			75		137		212			11	%	3	%	6	%		7	%	9	%	8	%		11	%	1	%	4	%		7	%	11	%	9	%
Advanced Surgery	147		112		259			137		93		230			127		86		213			7	%	20	%	13	%		8	%	8	%	8	%		7	%	15	%	10	%		8	%	12	%	9	%
Acute Therapies	82		139		221			48		96		144			45		91		136			71	%	45	%	53	%		7	%	5	%	6	%		71	%	40	%	50	%		7	%	8	%	7	%
BioPharma Solutions	48		67		115			64		53		117			53		59		112			(25)	%	26	%	(2)	%		21	%	(10)	%	4	%		(25)	%	19	%	(5)	%		21	%	(7)	%	6	%
Other	17		8		25			21		12		33			23		8		31			(19)	%	(33)	%	(24)	%		(9)	%	50	%	6	%		(19)	%	(50)	%	(30)	%		(9)	%	38	%	3	%
Total Baxter	$	1,290		$	1,891		$	3,181			$	1,289		$	1,750		$	3,039			$	1,172		$	1,661		$	2,833			0	%	8	%	5	%		10	%	5	%	7	%		0	%	5	%	3	%		10	%	7	%	8	%

	Quarters Ended September 30,
													Reported Growth		Constant Currency Growth
	2020		2019		2018		2020		2019		2020		2019
	U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total
Net sales by product category
Renal Care	$	216		$	739		$	955			$	199		$	719		$	918			$	209		$	698		$	907			9	%	3	%	4	%		(5)	%	3	%	1	%		9	%	3	%	4	%		(5)	%	6	%	4	%
Medication Delivery	419		246		665			446		240		686			405		234		639			(6)	%	3	%	(3)	%		10	%	3	%	7	%		(6)	%	3	%	(3)	%		10	%	6	%	9	%
Pharmaceuticals	209		330		539			212		304		516			243		278		521			(1)	%	9	%	4	%		(13)	%	9	%	(1)	%		(1)	%	5	%	3	%		(13)	%	14	%	2	%
Clinical Nutrition	87		147		234			77		139		216			81		137		218			13	%	6	%	8	%		(5)	%	1	%	(1)	%		13	%	1	%	6	%		(5)	%	6	%	2	%
Advanced Surgery	138		97		235			134		82		216			122		77		199			3	%	18	%	9	%		10	%	6	%	9	%		3	%	17	%	8	%		10	%	10	%	10	%
Acute Therapies	72		105		177			44		86		130			41		81		122			64	%	22	%	36	%		7	%	6	%	7	%		64	%	21	%	35	%		7	%	10	%	9	%
BioPharma Solutions	84		57		141			89		51		140			74		50		124			(6)	%	12	%	1	%		20	%	2	%	13	%		(6)	%	4	%	(2)	%		20	%	6	%	15	%
Other	19		7		26			23		6		29			19		12		31			(17)	%	17	%	(10)	%		21	%	(50)	%	(6)	%		(17)	%	50	%	(3)	%		21	%	(42)	%	(3)	%
Total Baxter	$	1,244		$	1,728		$	2,972			$	1,224		$	1,627		$	2,851			$	1,194		$	1,567		$	2,761			2	%	6	%	4	%		3	%	4	%	3	%		2	%	5	%	4	%		3	%	8	%	5	%

	Quarters Ended June 30,
													Reported Growth		Constant Currency Growth
	2020		2019		2018		2020		2019		2020		2019
	U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total
Net sales by product category
Renal Care	$	209		$	710		$	919			$	196		$	711		$	907			$	204		$	715		$	919			7	%	(0)	%	1	%		(4)	%	(1)	%	(1)	%		7	%	5	%	5	%		(4)	%	5	%	3	%
Medication Delivery	394		211		605			429		248		677			425		250		675			(8)	%	(15)	%	(11)	%		1	%	(1)	%	0	%		(8)	%	(10)	%	(9)	%		1	%	5	%	3	%
Pharmaceuticals	208		273		481			225		303		528			259		270		529			(8)	%	(10)	%	(9)	%		(13)	%	12	%	(0)	%		(8)	%	(6)	%	(6)	%		(13)	%	19	%	3	%
Clinical Nutrition	75		141		216			77		136		213			77		138		215			(3)	%	4	%	1	%		0	%	(1)	%	(1)	%		(3)	%	8	%	4	%		0	%	4	%	3	%
Advanced Surgery	94		74		168			143		88		231			118		85		203			(34)	%	(16)	%	(27)	%		21	%	4	%	14	%		(34)	%	(15)	%	(27)	%		21	%	11	%	17	%
Acute Therapies	72		114		186			44		88		132			42		85		127			64	%	30	%	41	%		5	%	4	%	4	%		64	%	35	%	45	%		5	%	9	%	8	%
BioPharma Solutions	54		62		116			54		58		112			62		49		111			0	%	7	%	4	%		(13)	%	18	%	1	%		0	%	10	%	5	%		(13)	%	24	%	4	%
Other	21		6		27			25		9		34			23		11		34			(16)	%	(33)	%	(21)	%		9	%	(18)	%	0	%		(16)	%	(33)	%	(21)	%		9	%	(9)	%	3	%
Total Baxter	$	1,127		$	1,591		$	2,718			$	1,193		$	1,641		$	2,834			$	1,210		$	1,603		$	2,813			(6)	%	(3)	%	(4)	%		(1)	%	2	%	1	%		(6)	%	1	%	(1)	%		(1)	%	8	%	4	%

	Quarters Ended March 31,
													Reported Growth		Constant Currency Growth
	2020		2019		2018		2020		2019		2020		2019
	U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total		U.S.	Int'l	Total
Net sales by product category
Renal Care	$	204		$	666		$	870			$	192		$	662		$	854			$	196		$	678		$	874			6	%	1	%	2	%		(2)	%	(2)	%	(2)	%		6	%	4	%	4	%		(2)	%	4	%	3	%
Medication Delivery	449		229		678			392		228		620			421		242		663			15	%	0	%	9	%		(7)	%	(6)	%	(6)	%		15	%	5	%	11	%		(7)	%	1	%	(4)	%
Pharmaceuticals	220		296		516			227		278		505			233		255		488			(3)	%	6	%	2	%		(3)	%	9	%	3	%		(3)	%	11	%	5	%		(3)	%	17	%	8	%
Clinical Nutrition	79		138		217			74		128		202			80		142		222			7	%	8	%	7	%		(8)	%	(10)	%	(9)	%		7	%	12	%	10	%		(8)	%	(4)	%	(5)	%
Advanced Surgery	137		87		224			119		79		198			98		84		182			15	%	10	%	13	%		21	%	(6)	%	9	%		15	%	14	%	15	%		21	%	(1)	%	11	%
Acute Therapies	60		96		156			48		81		129			46		84		130			25	%	19	%	21	%		4	%	(4)	%	(1)	%		25	%	22	%	23	%		4	%	5	%	5	%
BioPharma Solutions	48		66		114			50		50		100			55		47		102			(4)	%	32	%	14	%		(9)	%	6	%	(2)	%		(4)	%	36	%	16	%		(9)	%	17	%	3	%
Other	20		7		27			18		12		30			18		13		31			11	%	(42)	%	(10)	%		0	%	(8)	%	(3)	%		11	%	(42)	%	(10)	%		0	%	(8)	%	(3)	%
Total Baxter	$	1,217		$	1,585		$	2,802			$	1,120		$	1,518		$	2,638			$	1,147		$	1,545		$	2,692			9	%	4	%	6	%		(2)	%	(2)	%	(2)	%		9	%	8	%	8	%		(2)	%	5	%	2	%